Safe Save Medical Cell Sciences & Technology Co., Ltd
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
"Autologous Dendritic Cell/ Tumor Antigen" ADCTA cancer immunotherapy
The content above was translated by Ai
Founded Year
2011
Unified Business No.
53527046
Status
Active
Number of Employees
17
Total Paid-in
Capital
699,610,000 (NT$)
Location of Company
Taiwan
, Hsinchu County
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
SSC, Safe Save Medical Cell Sciences & Technology CO., Ltd was founded in 2011, engaged in the development of cancer immunotherapy, owns the technology of autologous Dendritic Cells/Tumor Antigens (ADCTA) immunotherapy, and develops autologous immune tailor made precision medicine, is the benchmark of immunotherapy industry in Taiwan.
Safe Save Cell adheres to the corporate philosophy of "R&D innovation, excellent quality and professional service". Combining advanced research and development, technology platform, business model and Industry-Governor-Academia collaboration, Safe Save Cell established in Taiwan and are ambitious to be the global medicine provider and embark ourselves the leading company in dendritic cell immunotherapy in the world.
Safe Save Cell adheres to the corporate philosophy of "R&D innovation, excellent quality and professional service". Combining advanced research and development, technology platform, business model and Industry-Governor-Academia collaboration, Safe Save Cell established in Taiwan and are ambitious to be the global medicine provider and embark ourselves the leading company in dendritic cell immunotherapy in the world.
The content above was translated by Ai
